Mechlorethamine Induced Contact Dermatitis Avoidance Study

Clinical trial NCT03380026 · COMPLETED

Trial details

NCT number: NCT03380026
Sponsor: Rochester Skin Lymphoma Medical Group, PLLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous T-cell Lymphoma Cutaneous T-cell Lymphoma Stage I Mycosis Fungoides Folliculotropic Mycosis Fungoides Granulomatous Slack Skin Syringotropic Mycosis Fungoides Mycosis Fungoides Variant Transformed Mycosis Fungoides

Start date: 2017-12-13
Primary completion: 2020-08-03
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.